Brief assessment of priority symptoms in hormone refractory prostate cancer: The FACT Advanced Prostate Symptom Index (FAPSI)
AUTOR(ES)
Yount, Susan
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=305353Documentos Relacionados
- Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI)
- Clodronate for treatment of bone metastases in hormone refractory prostate cancer
- Docetaxel prolongs life in men with hormone refractory prostate cancer
- First brazilian consensus of advanced prostate cancer: recommendations for clinical practice
- Recovery of hormone sensitivity after salvage brachytherapy for hormone refractory localized prostate cancer